Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001472827-25-000002
Filing Date
2025-03-03
Accepted
2025-03-03 16:36:21
Documents
1
Period of Report
2025-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1741037773.html 4  
1 FORM 4 wk-form4_1741037773.xml 4 3441
  Complete submission text file 0001472827-25-000002.txt   4855
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address
Solaiman Shereen (Reporting) CIK: 0001472827 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 25698634